SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-133637
Filing Date
2021-11-03
Accepted
2021-11-03 16:08:17
Documents
14
Period of Report
2021-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131730d1_8k.htm   iXBRL 8-K 26864
2 EXHIBIT 99.1 tm2131730d1_ex99-1.htm EX-99.1 67698
6 GRAPHIC tm2131730d1_ex99-1img01.jpg GRAPHIC 17915
  Complete submission text file 0001104659-21-133637.txt   309420

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20211103.xsd EX-101.SCH 3210
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20211103_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20211103_pre.xml EX-101.PRE 22727
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2131730d1_8k_htm.xml XML 3858
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 211375386
SIC: 2834 Pharmaceutical Preparations